By Iain Gilbert
Date: Wednesday 11 Oct 2023
(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.
Grant of Options | 15-Nov-2023 | 07:00 | RNS |
Appointment of New Chief Financial Officer | 11-Oct-2023 | 07:00 | RNS |
Interim Results | 21-Sep-2023 | 07:00 | RNS |
Result of AGM | 29-Jun-2023 | 18:02 | RNS |
Annual General Meeting Presentation | 29-Jun-2023 | 10:00 | RNS |
AstraZeneca buys the rights to an asthma treatme... | 13-Jun-2014 | Daily Mail |
AstraZeneca in new £138million asthma drug deal | 13-Jun-2014 | Express & Star |
Market report: Monday latest | 24-Sep-2007 | Daily Mail |
The Week Ahead: Wolseley should build on its sol... | 24-Sep-2007 | The Independent |
Questor: Synairgen | 11-May-2007 | Telegraph |
The Week Ahead: Wolseley investors seek calm ami... | 19-Mar-2007 | The Independent |
Retailers the focus of City attention | 18-Sep-2006 | The Scotsman |
No recent information was found.
Currency | UK Pounds |
Share Price | 6.49p |
Change Today | -0.100p |
% Change | -1.52 % |
52 Week High | 11.50 |
52 Week Low | 4.88 |
Volume | 203,677 |
Shares Issued | 201.37m |
Market Cap | £13.07m |
RiskGrade | 510 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 20 @ 6.21p |
16:27 | 27 @ 6.21p |
15:37 | 13,560 @ 6.74p |
14:53 | 7,383 @ 6.30p |
14:51 | 917 @ 6.21p |
You are here: research